pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
pegfilgrastim
Udenyca (pegfilgrastim-cbqv)
Febrile Neutropenia
Accord Biopharma Inc
0 catalysts
Preclinical
pegfilgrastim biosimilar
Fylnetra (pegfilgrastim-pbbk)
Unspecified Cancer
Meitheal Pharmaceuticals Inc
0 catalysts
Marketed
peginterferon alfa-2a
Pegasys (peginterferon alfa-2a)
Hepatitis B
pharmaand GmbH
0 catalysts
← prev
page 242 of 271
next →
131
Pain89
Neurology1
Marketed
peginterferon beta-1a
Plegridy (peginterferon beta-1a)
Progressive Relapsing Multiple Sclerosis (PRMS)
$BIIBBIOGEN INC.
0 catalysts
Phase 3
peginterferon lambda-1a
Coronavirus Disease 2019 (COVID-19)
Interferon lambda receptor
Eiger Inno Therapeutics Inc
0 catalysts
Marketed
pegloticase
Krystexxa (pegloticase)
Gouty Arthritis (Gout)
Horizon Therapeutics USA Inc
0 catalysts
Phase 1
pegmispotide
pegmispotide[INN]
Ulcerative Colitis
Adiso Therapeutics Inc
0 catalysts
Phase 3
pegozafermin
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
89bio Inc
0 catalysts
Phase 2
pegsebrenatide
pegsebrenatide [INN]
Multiple Sclerosis
Neuraly Inc
0 catalysts
Phase 2
pegtarazimod hydrochloride
Chronic Obstructive Pulmonary Disease (COPD)
ReAlta Life Sciences Inc
0 catalysts
Phase 3
pegtibatinase
Homocystinuria
$TVTXTravere Therapeutics, Inc.
0 catalysts
Phase 3
pegunigalsidase alfa
Elfabrio (pegunigalsidase alfa)
Fabry Disease
Chiesi Farmaceutici SpA
0 catalysts
Marketed
pegvaliase
Palynziq (pegvaliase [INN])
Hyperphenylalaninemia
$BMRNBIOMARIN PHARMACEUTICAL INC
0 catalysts
Marketed
pegvisomant
Somavert (pegvisomant)
Acromegaly
$PFEPFIZER INC
0 catalysts
Phase 3
pelabresib
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Bromodomain and extra-terminal motif (BET)
$NVSNOVARTIS AG
0 catalysts
Phase 2
pelareorep
Reolysin (pelareorep)
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$ONCYONCOLYTICS BIOTECH INC
0 catalysts
Phase 2
pelcitoclax
pelcitoclax [INN]
Neuroendocrine Tumors
$AAPGASCENTAGE PHARMA GROUP INTERNATIONAL
0 catalysts
Phase 2
peltopepimut-s
Cervical Cancer
ISA Pharmaceuticals BV
0 catalysts
Phase 2
peluntamig
Neuroendocrine Carcinoma
Phanes Therapeutics Inc
0 catalysts
Phase 3
pemafibrate
pemafibrate [INN]
Hypertriglyceridemia
Kowa Co Ltd
0 catalysts
Phase 2
pemafibrate + tofogliflozin
pemafibrate [INN] + tofogliflozin
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Kowa Co Ltd
0 catalysts
Phase 1
pembrolizumab biosimilar
Melanoma
Formycon AG
0 catalysts
Marketed
pemetrexed
Pemfexy (pemetrexed [INN])
Malignant Pleural Mesothelioma
Eagle Pharmaceuticals Inc
0 catalysts
Marketed
pemetrexed tromethamine
Pemetrexed Ditromethamine (pemetrexed tromethamine)
Malignant Pleural Mesothelioma
Hospira Inc
0 catalysts
Marketed
pemigatinib
Pemazyre (pemigatinib)
Metastatic Bile Duct Cancer
Fibroblast growth factor receptor 3Fibroblast growth factor receptor 1
$INCYINCYTE CORP
0 catalysts
Marketed
pemivibart
Pemgarda (pemivibart)
Coronavirus Disease 2019 (COVID-19)
$IVVDInvivyd, Inc.
0 catalysts
Phase 2
pemvidutide
Alcohol Use Disorder (AUD)
$ALTAltimmune, Inc.
0 catalysts
Phase 1
pemziviptadil
Vasomera (pemziviptadil [INN])
Cystic Fibrosis
ImmunoForge Co Ltd
0 catalysts
Marketed
penciclovir
Penciclovir (penciclovir)
Herpes Labialis (Oral Herpes)
Padagis LLC
0 catalysts
Marketed
penciclovir sodium
Penciclovir Sodium (penciclovir sodium)
Herpes Labialis (Oral Herpes)
Torrent Pharma Inc
0 catalysts